| Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model Y Liu, M Hu Drug Metabolism and Disposition 30 (4), 370-377, 2002 | 364 | 2002 |
| First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics B Wu, K Kulkarni, S Basu, S Zhang, M Hu Journal of pharmaceutical sciences 100 (9), 3655-3681, 2011 | 351 | 2011 |
| Metabolism of flavonoids via enteric recycling: role of intestinal disposition J Chen, H Lin, M Hu Journal of Pharmacology and Experimental Therapeutics 304 (3), 1228-1235, 2003 | 343 | 2003 |
| Bioavailability challenges associated with development of anti-cancer phenolics S Gao, M Hu Mini reviews in medicinal chemistry 10 (6), 550-567, 2010 | 278 | 2010 |
| Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME Z Yang, K Kulkarni, W Zhu, M Hu Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2012 | 229 | 2012 |
| In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy K Phe, Y Lee, PM McDaneld, N Prasad, T Yin, DA Figueroa, WL Musick, ... Antimicrobial agents and chemotherapy 58 (5), 2740-2746, 2014 | 212 | 2014 |
| Commentary: bioavailability of flavonoids and polyphenols: call to arms M Hu Molecular pharmaceutics 4 (6), 803-806, 2007 | 206 | 2007 |
| Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model M Hu, J Chen, H Lin Journal of Pharmacology and Experimental Therapeutics 307 (1), 314-321, 2003 | 185 | 2003 |
| Passive and carrier-mediated intestinal absorption components of captopril M Hu, GL Amidon Journal of pharmaceutical sciences 77 (12), 1007-1011, 1988 | 185 | 1988 |
| Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model J Chen, H Lin, M Hu Cancer chemotherapy and pharmacology 55, 159-169, 2005 | 180 | 2005 |
| Natural polyphenol disposition via coupled metabolic pathways Z Liu, M Hu Expert opinion on drug metabolism & toxicology 3 (3), 389-406, 2007 | 167 | 2007 |
| Glucuronidation: driving factors and their impact on glucuronide disposition G Yang, S Ge, R Singh, S Basu, K Shatzer, M Zen, J Liu, Y Tu, C Zhang, ... Drug metabolism reviews 49 (2), 105-138, 2017 | 163 | 2017 |
| Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P‐glycoprotein L Ye, T Wang, L Tang, W Liu, Z Yang, J Zhou, Z Zheng, Z Cai, M Hu, Z Liu Journal of pharmaceutical sciences 100 (11), 5007-5017, 2011 | 158 | 2011 |
| Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions EJ Jeong, X Liu, X Jia, J Chen, M Hu Current drug metabolism 6 (5), 455-468, 2005 | 141 | 2005 |
| Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones M Hu, K Krausz, J Chen, X Ge, J Li, HL Gelboin, FJ Gonzalez Drug Metabolism and Disposition 31 (7), 924-931, 2003 | 141 | 2003 |
| Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design K Abdelraouf, KH Braggs, T Yin, LD Truong, M Hu, VH Tam Antimicrobial agents and chemotherapy 56 (9), 4625-4629, 2012 | 138 | 2012 |
| Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates X Jia, J Chen, H Lin, M Hu Journal of pharmacology and experimental therapeutics 310 (3), 1103-1113, 2004 | 136 | 2004 |
| Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine ZQ Liu, ZH Jiang, L Liu, M Hu Pharmaceutical research 23, 2768-2780, 2006 | 132 | 2006 |
| Species-and disposition model-dependent metabolism of raloxifene in gut and liver: role of UGT1A10 EJ Jeong, Y Liu, H Lin, M Hu Drug metabolism and disposition 33 (6), 785-794, 2005 | 128 | 2005 |
| Use of the Peptide Carrier System to Improve the Intestinal Absorption of L-α-Methyldopa: Carrier Kinetics, Intestinal Permeabilities, and In Vitro Hydrolysis of … M Hu, P Subramanian, HI Mosberg, GL Amidon Pharmaceutical research 6, 66-70, 1989 | 127 | 1989 |
Baojian WuJinan UniversityVerified email at jnu.edu.cn
